Abbott Laboratories Stock price
Equities
ABT
US0028241000
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
111.8 USD | -0.55% | -0.27% | +1.58% |
Feb. 09 | US FDA staff raises no new concerns about Abbott's heart device | RE |
Feb. 08 | Dexcom beats profit estimates on strong demand for glucose monitors | RE |
Financials (USD)
Sales 2023 | 40.11B | Sales 2024 * | 41.98B | Capitalization | 194B |
---|---|---|---|---|---|
Net income 2023 | 5.72B | Net income 2024 * | 6.04B | EV / Sales 2023 | 4.76 x |
Net Debt 2023 * | 6.36B | Net Debt 2024 * | 2.86B | EV / Sales 2024 * | 4.69 x |
P/E ratio 2023 |
33.8
x | P/E ratio 2024 * |
32.3
x | Employees | 115,000 |
Yield 2023 * |
1.84% | Yield 2024 * |
1.96% | Free-Float | 86.87% |
Latest transcript on Abbott Laboratories
1 day | -0.55% | ||
1 week | -0.27% | ||
Current month | -1.18% | ||
1 month | -0.82% | ||
3 months | +19.52% | ||
6 months | +6.18% | ||
Current year | +1.58% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 50 | - |
Philip Boudreau
DFI | Director of Finance/CFO | 51 | 96-12-31 |
Scott House
CTO | Chief Tech/Sci/R&D Officer | - | 20-02-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Starks
BRD | Director/Board Member | 69 | 17-02-15 |
John Stratton
BRD | Director/Board Member | 63 | 17-06-28 |
Nancy McKinstry
BRD | Director/Board Member | 65 | 11-12-08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.18% | 19 M€ | +2.97% | - | |
5.19% | 2 M€ | -.--% | ||
3.00% | 2 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-02-09 | 111.8 | -0.55% | 5,947,680 |
24-02-08 | 112.4 | -0.78% | 6,980,455 |
24-02-07 | 113.3 | -0.61% | 4,757,532 |
24-02-06 | 114 | +2.10% | 4,734,844 |
24-02-05 | 111.6 | -0.41% | 5,670,059 |
Delayed Quote Nyse, February 09, 2024 at 04:00 pm EST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.58% | 194 B $ | |
+3.17% | 113 B $ | |
-2.92% | 46 443 M $ | |
+12.32% | 45 970 M $ | |
+1.73% | 42 088 M $ | |
+16.34% | 30 309 M $ | |
+17.68% | 27 044 M $ | |
+0.90% | 25 663 M $ | |
-3.17% | 25 468 M $ | |
+4.55% | 24 884 M $ |